ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
In brief
Ambrisentan is an endothelin receptor antagonist used for the treatment of pulmonary hypertension (PH). Based on research suggesting a role for endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and the poor prognosis for patients with IPF who are also diagnosed with PH, this study was designed to evaluate the effectiveness and safety of ambrisentan in that patient population.
Key facts
- Study ID
- NCT00879229
- Run by
- Gilead Sciences
- People needed
- 40
- Starts
- 2009-07-01
- Expected to finish
- 2011-02-01
- Last updated by the study team
- 2014-05-15
Who can join
Age: 35 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Arizona — Scottsdale, Arizona, United States
- University of California Davis — Davis, California, United States
- David Geffen School of Medicine UCLA — Los Angeles, California, United States
- University of California San Diego Medical Center — San Diego, California, United States
- University of California at San Francisco — San Francisco, California, United States
- Stanford University — Stanford, California, United States
- University of Colorado Heatlh Sciences Center — Aurora, Colorado, United States
- Bay Area Chest Physicians — Clearwater, Florida, United States
- University of Florida — Gainesville, Florida, United States
- University of Miami Medical Center — Miami, Florida, United States
- Suncoast Lung Center — Sarasota, Florida, United States
- Sarasota Memorial Hospital — Sarasota, Florida, United States
- Cleveland Clinic Florida — Weston, Florida, United States
- Atlanta Institute for Medical Research — Decatur, Georgia, United States
- University of Chicago — Chicago, Illinois, United States
- Kentuckiana Pulmonary Association — Louisville, Kentucky, United States
- Maine Medical Center — Portland, Maine, United States
- Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Boston University Medical Center — Boston, Massachusetts, United States
- Beth Israel Deacones Medical Center — Boston, Massachusetts, United States
- University of Michigan Health Systems — Ann Arbor, Michigan, United States
- Mayo Clinic Rochester — Rochester, Minnesota, United States
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.